Marina C. Garassino, MD, on COVID-19 and Thoracic Malignancies: TERAVOLT Registry
Marina C. Garassino, MD, of the Istituto Nazionale dei Tumori di Milano, discusses the global registry she and her colleagues created to track and address the 35% higher mortality risk from COVID-19 among patients with lung cancer who are treated with chemotherapy.